Raymond James Upgrade Boosts Oscar Health Stock After Q4 Earnings
I'm PortAI, I can summarize articles.
Oscar Health Inc (NYSE:OSCR) shares rose after the company reported Q4 results that missed revenue and earnings expectations but provided a strong 2026 outlook. The stock gained momentum following Raymond James' upgrade from Market Perform to Outperform, with a price target of $18. Oscar's 2026 revenue guidance of $18.7 billion to $19.0 billion significantly exceeds analysts' estimates, and the firm anticipates improved EBIT margins in the coming years. As of Thursday, OSCR shares were up 0.96% at $13.73.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments